Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Patrick, Marsall"'
Autor:
Nathalie Verónica Fernández Villalobos, Patrick Marsall, Johanna Carolina Torres Páez, Julia Strömpl, Jens Gruber, Martín Lotto Batista, Daria Pohl, Gustavo Concha, Hagen Frickmann, Fernando Pio de la Hoz Restrepo, Nicole Schneiderhan-Marra, Gérard Krause, Alex Dulovic, Monika Strengert, Simone Kann
Publikováno v:
Communications Medicine, Vol 3, Iss 1, Pp 1-8 (2023)
Abstract Background Although anti-SARS-CoV-2 humoral immune responses and epidemiology have been extensively studied, data gaps remain for certain populations such as indigenous people or children especially in low- and middle-income countries. To ad
Externí odkaz:
https://doaj.org/article/d90bfb0b882741b1bb98ce5a71eedb75
Autor:
Henning Jacobsen, Monika Strengert, Henrike Maaß, Mario Alberto Ynga Durand, Maeva Katzmarzyk, Barbora Kessel, Manuela Harries, Ulfert Rand, Leila Abassi, Yeonsu Kim, Tatjana Lüddecke, Kristin Metzdorf, Pilar Hernandez, Julia Ortmann, Jana-Kristin Heise, Stefanie Castell, Daniela Gornyk, Stephan Glöckner, Vanessa Melhorn, Yvonne Kemmling, Berit Lange, Alex Dulovic, Patrick Marsall, Julia Häring, Daniel Junker, Nicole Schneiderhan-Marra, Markus Hoffmann, Stefan Pöhlmann, Gérard Krause, Luka Cicin-Sain
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-11 (2022)
Abstract SARS-CoV-2 variants accumulating immune escape mutations provide a significant risk to vaccine-induced protection against infection. The novel variant of concern (VoC) Omicron BA.1 and its sub-lineages have the largest number of amino acid a
Externí odkaz:
https://doaj.org/article/82cbc1d3329f41c08faa87f7a7550462
Autor:
Lars Pelz, Elena Piagnani, Patrick Marsall, Nancy Wynserski, Marc Dominique Hein, Pavel Marichal-Gallardo, Sascha Young Kupke, Udo Reichl
Publikováno v:
Viruses, Vol 15, Iss 9, p 1872 (2023)
New broadly acting and readily available antiviral agents are needed to combat existing and emerging viruses. Defective interfering particles (DIPs) of influenza A virus (IAV) are regarded as promising options for the prevention and treatment of IAV
Externí odkaz:
https://doaj.org/article/6e9ede8ffa674c76984914b8a83d92f0
Autor:
Serafina Calarco, B Leticia Fernandez-Carballo, Thomas Keller, Stephan Weber, Meike Jakobi, Patrick Marsall, Nicole Schneiderhan-Marra, Sabine Dittrich
Publikováno v:
PLoS ONE, Vol 18, Iss 1, p e0267516 (2023)
Accurate and precise point-of-care (POC) testing for C-reactive protein (CRP) can help support healthcare providers in the clinical management of patients. Here, we compared the analytical performance of 17 commercially available POC CRP tests to ena
Externí odkaz:
https://doaj.org/article/b4316436f08949d4b18e4e07b6289c56
Autor:
Günalp Uzun, Rebecca Müller, Karina Althaus, Matthias Becker, Patrick Marsall, Daniel Junker, Stefanie Nowak-Harnau, Nicole Schneiderhan-Marra, Harald Klüter, Hubert Schrezenmeier, Peter Bugert, Tamam Bakchoul
Publikováno v:
Viruses, Vol 15, Iss 6, p 1357 (2023)
COVID-19 convalescent plasma (CCP) with high neutralizing antibodies has been suggested in preventing disease progression in COVID-19. In this study, we investigated the relationship between clinical donor characteristics and neutralizing anti-SARS-C
Externí odkaz:
https://doaj.org/article/4f494d8828204975b15f6a0ffb630716
Autor:
Bakchoul, Günalp Uzun, Rebecca Müller, Karina Althaus, Matthias Becker, Patrick Marsall, Daniel Junker, Stefanie Nowak-Harnau, Nicole Schneiderhan-Marra, Harald Klüter, Hubert Schrezenmeier, Peter Bugert, Tamam
Publikováno v:
Viruses; Volume 15; Issue 6; Pages: 1357
COVID-19 convalescent plasma (CCP) with high neutralizing antibodies has been suggested in preventing disease progression in COVID-19. In this study, we investigated the relationship between clinical donor characteristics and neutralizing anti-SARS-C
Autor:
Daniel, Junker, Matthias, Becker, Teresa R, Wagner, Philipp D, Kaiser, Sandra, Maier, Tanja M, Grimm, Johanna, Griesbaum, Patrick, Marsall, Jens, Gruber, Bjoern, Traenkle, Constanze, Heinzel, Yudi T, Pinilla, Jana, Held, Rolf, Fendel, Andrea, Kreidenweiss, Annika, Nelde, Yacine, Maringer, Sarah, Schroeder, Juliane S, Walz, Karina, Althaus, Gunalp, Uzun, Marco, Mikus, Tamam, Bakchoul, Katja, Schenke-Layland, Stefanie, Bunk, Helene, Haeberle, Siri, Göpel, Michael, Bitzer, Hanna, Renk, Jonathan, Remppis, Corinna, Engel, Axel R, Franz, Manuela, Harries, Barbora, Kessel, Berit, Lange, Monika, Strengert, Gerard, Krause, Anne, Zeck, Ulrich, Rothbauer, Alex, Dulovic, Nicole, Schneiderhan-Marra
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
The rapid emergence of the omicron variant and its large number of mutations led to its classification as a variant of concern (VOC) by the WHO. Subsequently, omicron evolved into distinct sublineages (e.g. BA1 and BA2), which currently represent the
Autor:
Daniel Junker, Matthias Becker, Teresa R. Wagner, Philipp D. Kaiser, Sandra Maier, Tanja M. Grimm, Johanna Griesbaum, Patrick Marsall, Jens Gruber, Bjoern Traenkle, Constanze Heinzel, Yudi T. Pinilla, Jana Held, Rolf Fendel, Andrea Kreidenweiss, Annika Nelde, Yacine Maringer, Sarah Schroeder, Juliane S. Walz, Karina Althaus, Gunalp Uzun, Marco Mikus, Tamam Bakchoul, Katja Schenke-Layland, Stefanie Bunk, Helene Haeberle, Siri Göpel, Michael Bitzer, Hanna Renk, Jonathan Remppis, Corinna Engel, Axel R. Franz, Manuela Harries, Barbora Kessel, Monika Strengert, Gerard Krause, Anne Zeck, Ulrich Rothbauer, Alex Dulovic, Nicole Schneiderhan-Marra
The rapid emergence of the Omicron variant and its large number of mutations has led to its classification as a variant of concern (VOC) by the WHO(1). Initial studies on the neutralizing response towards this variant within convalescent and vaccinat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a78496458daf8d61dd95f92e345463d4
https://doi.org/10.1101/2021.12.30.21267519
https://doi.org/10.1101/2021.12.30.21267519
Autor:
Daniel Junker, Matthias Becker, Teresa R Wagner, Philipp D Kaiser, Sandra Maier, Tanja M Grimm, Johanna Griesbaum, Patrick Marsall, Jens Gruber, Bjoern Traenkle, Constanze Heinzel, Yudi T Pinilla, Jana Held, Rolf Fendel, Andrea Kreidenweiss, Annika Nelde, Yacine Maringer, Sarah Schroeder, Juliane S Walz, Karina Althaus, Gunalp Uzun, Marco Mikus, Tamam Bakchoul, Katja Schenke-Layland, Stefanie Bunk, Helene Haeberle, Siri Göpel, Michael Bitzer, Hanna Renk, Jonathan Remppis, Corinna Engel, Axel R Franz, Manuela Harries, Barbora Kessel, Berit Lange, Monika Strengert, Gerard Krause, Anne Zeck, Ulrich Rothbauer, Alex Dulovic, Nicole Schneiderhan-Marra
Publikováno v:
Clinical Infectious Diseases. 76(3):e240-e249
Background The rapid emergence of the Omicron variant and its large number of mutations led to its classification as a variant of concern (VOC) by the World Health Organization. Subsequently, Omicron evolved into distinct sublineages (eg, BA.1 and BA